Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
M DuvicBexarotene Worldwide Study Group

Abstract

Cutaneous T-cell lymphomas (CTCL) are malignancies of T cells appearing as skin lesions and are responsive to retinoid therapy. Safety and efficacy of a novel RXR-selective retinoid (rexinoid) bexarotene (Targretin, LGD1069; Ligand Pharmaceuticals Inc, San Diego, CA) was evaluated as a single-agent oral therapy administered once daily in an open-label study in patients with refractory advanced-stage CTCL. Ninety-four patients with biopsy-confirmed CTCL in advanced stages (IIB-IVB) were enrolled at 26 centers. Fifty-six patients received an initial dose of 300 mg/m2/d oral bexarotene and 38 started at more than 300 mg/m2/d. Clinical complete and partial responses were reported by Primary End point Classification for the study in 45% (25 of 56) of patients enrolled at 300 mg/m2/d dosing. At more than 300 mg/m2/d, 55% (21 of 38) of patients responded, including 13% (five of 38) clinical complete. For the 300 mg/m2/d initial dose group, the rate of relapse after response was 36% and the projected median duration of response was 299 days. Improvements were also seen in overall body-surface area involvement, median index lesion surface area, adenopathy, cutaneous tumors, pruritus, and CTCL-specific quality of life. The most frequent ...Continue Reading

References

Feb 1, 1991·Journal of the American Academy of Dermatology·R M KnoblerM Micksche
Jul 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T M KuzelS T Rosen
Jun 1, 1986·The Journal of Dermatologic Surgery and Oncology·J E Fitzpatrick, J R Mellette
Jan 1, 1987·Journal of the American Academy of Dermatology·J TousignantM J Light
Sep 10, 1983·Lancet·R P WarrellL M Itri
Aug 1, 1981·The American Journal of Medicine·L E PosnerP A Bunn
Jan 1, 1981·Journal of Chronic Diseases·W O SpitzerB R Catchlove
Jan 1, 1995·Recent Progress in Hormone Research·P Chambon
Sep 2, 1994·Journal of Medicinal Chemistry·M F BoehmR A Heyman
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W S VelasquezF Cabanillas
Feb 1, 1993·International Journal of Dermatology·G F AltomareA F Finzi
Jun 1, 1996·Journal of the American Academy of Dermatology·M DuvicR Kurzrock
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V A MillerR P Warrell
Apr 4, 1998·The American Journal of Cardiology·R L Ellen, R McPherson
May 20, 1998·Dermatologic Clinics·A A Sinha, P Heald
Mar 10, 1999·Journal of the American Academy of Dermatology·H S ZackheimA McMillan
Apr 8, 1999·The New England Journal of Medicine·S I ShermanM Duvic
May 20, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·F E FoxA H Rook
Aug 12, 1999·The New England Journal of Medicine·R H Knopp
Jan 8, 2000·Dermatologic Clinics·M Duvic, J C Cather
Mar 11, 2000·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·R P BerminghamR D Scalley
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E OlsenJ Nichols

❮ Previous
Next ❯

Citations

Jun 20, 2003·American Journal of Clinical Dermatology·Arash Akhavan, Susan Bershad
Sep 3, 2003·European Journal of Haematology·G A KennedyH M Prince
Jan 18, 2005·Skinmed·Alexander RoeschmThomas Vogt
Oct 1, 2004·Anti-cancer Drugs·Andres J SchraderRainer Hofmann
Jun 14, 2005·The British Journal of Dermatology·S BrennandH M Prince
Nov 12, 2005·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·J BohmeyerW Sterry
Jun 1, 2006·American Journal of Clinical Dermatology·Margit A HuberKarin Scharffetter-Kochanek
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elise A OlsenMadeleine Duvic
Nov 25, 2006·Hematology·Steven T Rosen, Christiane Querfeld
Aug 29, 2007·American Journal of Hematology·Donald E TsaiDan T Vogl
Nov 6, 2007·Expert Opinion on Emerging Drugs·M A M van Steensel
Nov 21, 2007·International Reviews of Immunology·Takaomi Sanda
Mar 12, 2008·Chemotherapy·Jonathan D WildiRamaswamy Govindan
Jun 10, 2008·Expert Opinion on Emerging Drugs·Dominik Sebastian MestelWolfram Sterry
Nov 8, 2008·Expert Opinion on Biological Therapy·Dominik Sebastian MestelChalid Assaf
Oct 23, 2009·Experimental Dermatology·Anne Chantal KnolBrigitte Dréno
Mar 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H Miles PrinceAndres Negro-Vilar
Mar 31, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Madeleine DuvicChitra Hosing
Jul 24, 2010·Expert Opinion on Investigational Drugs·Takashi Watanabe
Mar 1, 2012·Seminars in Cutaneous Medicine and Surgery·Brian Poligone, Peter Heald
Mar 16, 2012·Future Medicinal Chemistry·Sophia RangwalaMadeleine Duvic
Sep 14, 2012·Photodermatology, Photoimmunology & Photomedicine·Robert KnoblerLarisa Geskin
Aug 2, 2013·Future Oncology·Reinhard DummerAntonio Cozzio
Dec 19, 2014·BioMedicine·Mei-Chih ChenTsung-Ying Yang
Nov 27, 2015·American Journal of Hematology·Ryan A Wilcox
Aug 5, 2017·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·J P Nicolay, C Assaf
Aug 23, 2017·Expert Opinion on Biological Therapy·Mauro Alaibac
Jun 12, 2018·The Journal of Dermatological Treatment·Iris Amitay-LaishEmmilia Hodak
Oct 17, 2018·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Franz Trautinger
Jan 12, 2019·Leukemia & Lymphoma·Niloufer Khan, Steven Horwitz
Jun 6, 2019·Blood·Michi M Shinohara, Andrei Shustov
Jul 16, 2019·Expert Opinion on Drug Safety·Salma AfifiFrancine Foss
Aug 17, 2019·Frontiers in Oncology·Shaheer Khan, Ahmed Sawas
Aug 10, 2019·Expert Opinion on Investigational Drugs·Egle RamelyteEmmanuella Guenova
Sep 19, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S KhodadoustYoun H Kim
Nov 28, 2001·Hematology·J P GreerT P Loughran
Jun 30, 2004·Leukemia & Lymphoma·D A PichardoS T Rosen
Nov 18, 2003·The Australasian Journal of Dermatology·H Miles PrinceChris Baker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.